Login / Signup

[WHO Guideline for Screening and Treatment of Cervical Pre-Cancerous Lesions for Cervical Cancer Prevention (Second Edition)].

Julia HarlfingerIsolde SommerGerald Gartlehner
Published in: Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) (2023)
The updated and extended guideline contains 23 recommendations and seven good practice statements which address screening methods, test regimens, age groups, screening intervals and other topics. Target populations are adult females without known risk factors (general population) and women living with HIV. It is recommended that women from the general population undergo screening every five to ten years, starting at the age of 30. Women living with HIV are advised to get screened every three to five years, starting at the age of 25. Preferred primary screening tests are HPV DNA tests which may be supplemented with further tests in order to triage for further interventions.
Keyphrases
  • polycystic ovary syndrome
  • risk factors
  • emergency department
  • primary care
  • cervical cancer screening
  • type diabetes
  • pregnant women
  • skeletal muscle
  • cell free
  • single molecule
  • nucleic acid